Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. ENOV
7. AON
8. BLSM
9. AZN
10. EIX

Go back to Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
(NASDAQ: SILO) Delayed: 2.50 +0.02 (0.81%)
Previous Close $2.48    52 Week High $ 
Open $2.56    52 Week Low $ 
Day High $2.56    P/E N/A 
Day Low $2.45    EPS $ 
Volume 6,467